“IDH-mutant glioblastomas” were often considered secondary neoplasms (i.e., progressed from lower-grade IDH-mutant astrocytomas), while IDH-wildtype glioblastomas typically represented de novo neoplasms, mainly in older adults (9). Here, IDH2 is linked to glioblastoma.